Skip to main content

Closed

ONC: BeOne Medicines AG Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Revenue growth+55.0% / yr

Operating margin12.0%

ROIC7.7%

Financially safe

Strong

Debt / equity0.43×

Interest coverage12.8×

Current ratio3.64×

Valuation

Unrated

P/E ratio4.7×

BeOne Medicines AG

ONCNASDAQ·USD·Closed

BeOne Medicines AG

ONCNASDAQ·USD·Closed

$316.01

−1.88%

$316.01

−$6.07 (1.88%)

52W Range

47thpctl

Volume

0.80×avg

Mkt Cap

33.77BUSD

P/E

4.7TTM

Div Yield

–ann

52W Range

47thpctl

Volume

0.80×avg

Market Cap

33.77BUSD

P/E Ratio

4.7TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings